US Bancorp’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18
| Closed | -$23 | – | 4221 |
|
|
2023
Q3 | $23 | Hold |
18
| – | – | ﹤0.01% | 3961 |
|
|
2023
Q2 | $21 | Sell |
18
-1
| -5% | -$6 | ﹤0.01% | 3968 |
|
|
2023
Q1 | $198 | Hold |
19
| – | – | ﹤0.01% | 4022 |
|
|
2022
Q4 | $309 | Hold |
19
| – | – | ﹤0.01% | 4040 |
|
|
2022
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 4275 |
|
|
2022
Q2 | $0 | Hold |
19
| – | – | ﹤0.01% | 4300 |
|
|
2022
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 4040 |
|
|
2021
Q4 | $2K | Hold |
19
| – | – | ﹤0.01% | 3948 |
|
|
2021
Q3 | $2K | Hold |
19
| – | – | ﹤0.01% | 3945 |
|
|
2021
Q2 | $2K | Hold |
19
| – | – | ﹤0.01% | 3874 |
|
|
2021
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 3660 |
|
|
2020
Q4 | $2K | Sell |
19
-4
| -17% | -$570 | ﹤0.01% | 3622 |
|
|
2020
Q3 | $3K | Buy |
23
+20
| +667% | +$4.04K | ﹤0.01% | 3456 |
|
|
2020
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 3680 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 3849 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 3763 |
|
|
2019
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 3536 |
|
|
2019
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 3582 |
|
|
2019
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 3543 |
|
|
2018
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 3543 |
|
|
2018
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 3519 |
|
|
2018
Q2 | $5K | Hold |
3
| – | – | ﹤0.01% | 3339 |
|
|
2018
Q1 | $7K | Hold |
3
| – | – | ﹤0.01% | 3262 |
|
|
2017
Q4 | $17K | Hold |
3
| – | – | ﹤0.01% | 2995 |
|
|
2017
Q3 | $30K | Hold |
3
| – | – | ﹤0.01% | 2768 |
|
|
2017
Q2 | $34K | Buy |
+3
| New | +$42.4K | ﹤0.01% | 2711 |
|
US Bancorp's BIOC Position: Q4 2023 in Review
US Bancorp sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 18 shares — an estimated $23 sold.
US Bancorp first reported a position in BIOC in Q2 2017 and held it in 26 quarters. The position peaked at $34K in Q2 2017. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.
- US Bancorp reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
- US Bancorp sold 18 Biocept, Inc. shares in Q4 2023, an estimated $23.
- US Bancorp first reported a position in Biocept, Inc. in Q2 2017 and held it in 26 quarters.
- US Bancorp's Biocept, Inc. position peaked at $34K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.
Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.